Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Assembly Biosciences (NQ: ASMB )

5.830 USD -0.110 (-1.85%)
Streaming Delayed Price Updated: 2:08 PM EST, Jan 27, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Assembly Biosciences

< Previous 1 2 3 4 Next >
Assembly Biosciences to Wind-Down Microbiome Program
Company will prioritize resources to focus on advancement of novel HBV therapeutic portfolio 
From GlobeNewswire News Releases
Assembly Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From GlobeNewswire News Releases
Assembly Biosciences Appoints Nicole S. White, PhD, as Senior Vice President of Pharmaceutical Development and Manufacturing
From GlobeNewswire News Releases
Assembly Biosciences and Door Pharmaceuticals Sign Collaboration and Option Agreement to Develop a Novel Class of HBV Core Protein Modulators
From GlobeNewswire News Releases
Assembly Biosciences Presents Data from HBV Core Inhibitor Programs in Poster Sessions at the 2020 AASLD The Liver Meeting Digital Experience™
From GlobeNewswire News Releases
Assembly Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From GlobeNewswire News Releases
Assembly Biosciences Reports Third Quarter 2020 Financial Results and Business Update
From GlobeNewswire News Releases
Assembly Biosciences Provides Update on the Ongoing Phase 2 Extension Study of Vebicorvir in Patients with Chronic Hepatitis B Virus Infection
From GlobeNewswire News Releases
Multiple Abstracts Highlighting Assembly Biosciences’ Hepatitis B Core Inhibitor Development Programs Accepted for Presentation at the 2020 AASLD The Liver Meeting Digital Experience™
From GlobeNewswire News Releases
Assembly Biosciences Appoints Gina Consylman to Board of Directors
From GlobeNewswire News Releases
Assembly Biosciences CEO Dr. John McHutchison Named Recipient of the Prestigious Advance 2020 Global Impact Award
Dr. McHutchison Recognized for Critical Achievements in Developing Curative Treatments for Chronic Hepatitis 
From GlobeNewswire News Releases
Assembly Biosciences Announces October Conference Participation
From GlobeNewswire News Releases
Assembly Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From GlobeNewswire News Releases
Assembly Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From GlobeNewswire News Releases
Clinical Data from Assembly Biosciences’ HBV Core Inhibitors Presented at The Digital International Liver CongressTM EASL 2020
From GlobeNewswire News Releases
Assembly Biosciences and Arbutus Biopharma Announce Clinical Collaboration Agreement to Evaluate the Combination of Core Inhibitor ABI-H0731 with RNAi Therapeutic AB-729 in Patients with Chronic Hepat
From GlobeNewswire News Releases
Assembly Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From GlobeNewswire News Releases
Assembly Biosciences Reports Second Quarter 2020 Financial Results and Recent Highlights
From GlobeNewswire News Releases
Assembly Biosciences and BeiGene Announce License and Collaboration Agreement in China for Assembly’s Portfolio of Three Clinical-Stage Core Inhibitors for Chronic Hepatitis B Infection
From GlobeNewswire News Releases
Assembly Biosciences Announces FDA Fast Track Designation Granted to ABI-H2158 for the Treatment of Chronic Hepatitis B Virus Infection
From GlobeNewswire News Releases
Assembly Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From GlobeNewswire News Releases
Assembly Biosciences Initiates Phase 2 Trial Evaluating Second-Generation Core Inhibitor ABI-H2158 for Chronic Hepatitis B Infection
From GlobeNewswire News Releases
Preclinical Data from Assembly Biosciences’ Immuno-Oncology Microbiome Program Featured at AACR’s Virtual Annual Meeting II
From GlobeNewswire News Releases
Assembly Biosciences Regains Worldwide Rights to Microbiome Gastrointestinal Development Programs
From GlobeNewswire News Releases
Assembly Biosciences Announces Management Transition
From GlobeNewswire News Releases
Assembly Biosciences to Present During the Jefferies Virtual Healthcare Conference
From GlobeNewswire News Releases
Assembly Biosciences Announces Move to Virtual-Only Annual Meeting of Stockholders on June 11, 2020
From GlobeNewswire News Releases
Assembly Biosciences Reports Updates on Corporate Progress and First Quarter 2020 Financial Results
From GlobeNewswire News Releases
Preclinical Data from Assembly Biosciences’ Microbiome Program in Ulcerative Colitis Featured in DDW 2020 Virtual Meeting Portal and Upcoming Journal Supplements
From GlobeNewswire News Releases
Assembly Biosciences Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
From GlobeNewswire News Releases
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.